The global Anatomic Pathology Market is expected to reach a valuation of USD 22 billion by the end of 2022, according to the latest research report from Market Research Future (MRFR).
The report presents a detailed analysis of the global anatomic pathology market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global anatomic pathology market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period. Various components of the global anatomic pathology market are also studied in the report and projections are made for the growth trajectory of each distinct component from 2016 to 2022. The various segments and sub-segments within the global anatomic pathology market are studied in detail in the report. The study also makes a detailed analysis of the major players operating in the global anatomic pathology market and provides a detailed look at the various competitive strategies employed by players in the global anatomic pathology market. Likely future conditions with respect to the competitive landscape of the market are also explained in detail in the report.
Anatomic pathology differs from clinical pathology in the major point that clinical pathology relies on body fluids such as saliva or urine to diagnose diseases, whereas anatomic pathology relies on a direct study of the affected tissue or organ. The anatomic pathology methods can sometimes be more accurate than clinical pathology, due to the direct examination incorporated in the former. This has been the major driver for the global anatomical pathology market, as the demand for more accurate diagnostics has grown rapidly in the healthcare sector. Anatomic pathology also includes the study of tissue samples and biopsies.
Request For Free Sample Copy :https://www.marketresearchfuture.com/sample_request/2409
Leading players in the global anatomic pathology market include VolitionRx, Tecan, Sakura Finetek USA, RareCyte, Oxford Cancer Biomarkers, Omnyx, Nucleix, Monogram Biosciences, Janssen Diagnostic, Epic Sciences, Enzo Biochem, Digipath, Cancer Genetics, CellMax Life, Biocartis, Biocare Medical, AutoGenomics, Angsana Molecular & Diagnostics Laboratory, Agendia, Advanced Cell Diagnostics, AdnaGen, Abcam, Thermo Fisher Scientific, Roche Diagnostics, Danaher, Agilent Technologies, and Abbott Diagnostics.
The global anatomic pathology market is segmented on the basis of type, application, and region.
On the basis of type, the global anatomic pathology market is segmented into instruments, consumables, and services.
By application, the global anatomic pathology market is segmented into disease diagnostics, drug development, and others. The disease diagnostics segment holds a dominant share in the global anatomic pathology market due to the widespread use of anatomic pathology for disease diagnostics. The disease diagnostics segment accounted for close to 60% of the global anatomic pathology market in 2015, and is likely to retain a similar level of dominance over the forecast period. The drug discovery segment accounted for a further 30% of the global anatomic pathology market.
Browse Complete Toc :https://www.marketresearchfuture.com/reports/anatomic-pathology-market-2409
North America is the largest regional market for anatomic pathology, with the presence of several leading players in the region driving the regional market to new highs in the last few years. The North America market is likely to retain its dominance in the global anatomic pathology market over the forecast period, followed by Europe and Asia Pacific. The presence of an advanced healthcare sector in North America is also likely to be a major driver for the anatomic pathology market in the region. The presence of sophisticated tissue sampling procedures in North America has led to a strong development of anatomic pathology market channels in the region. This is likely to be a major driver for the global anatomic pathology market over the forecast period.
Europe is the second largest regional market for anatomic pathology, with Asia Pacific following in third place. The Asia Pacific market is likely to be crucial for the global market over the forecast period due to the steady growth of the healthcare sector in countries such as Japan, South Korea, China, and Australia.